ISRIB
ISRIB (Integrated Stress Response Inhibitor) is a small molecule that has been identified as a potent inhibitor of the integrated stress response (ISR). The ISR is a cellular response to various forms of stress, including endoplasmic reticulum stress, oxidative stress, and amino acid deprivation. ISRIB has shown promise in preclinical studies for its potential therapeutic applications in various neurological and cognitive disorders.
Mechanism of Action[edit | edit source]
ISRIB functions by inhibiting the phosphorylation of the eukaryotic initiation factor 2 alpha (eIF2α), a key step in the ISR pathway. Under stress conditions, eIF2α is phosphorylated by kinases such as PERK, PKR, GCN2, and HRI, leading to a reduction in global protein synthesis and the activation of stress response genes. ISRIB prevents this phosphorylation, thereby maintaining normal protein synthesis and cellular function.
Therapeutic Potential[edit | edit source]
ISRIB has been studied for its potential to treat a variety of conditions, including:
- Traumatic brain injury (TBI): Preclinical studies have shown that ISRIB can improve cognitive function and memory in animal models of TBI.
- Neurodegenerative diseases: ISRIB has demonstrated potential in models of Alzheimer's disease and other neurodegenerative conditions by reducing the accumulation of misfolded proteins and improving neuronal function.
- Cognitive disorders: ISRIB has been shown to enhance cognitive performance in animal models, suggesting potential applications in conditions such as Down syndrome and age-related cognitive decline.
Research and Development[edit | edit source]
ISRIB was first identified by researchers at the University of California, San Francisco (UCSF) in 2013. Since then, it has been the subject of numerous studies aimed at understanding its mechanism of action and therapeutic potential. Ongoing research is focused on optimizing ISRIB's pharmacokinetic properties and evaluating its safety and efficacy in clinical trials.
See Also[edit | edit source]
- Integrated stress response
- Endoplasmic reticulum stress
- Neurodegenerative diseases
- Cognitive disorders
References[edit | edit source]
External Links[edit | edit source]
Translate: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD